Golden Pear Funding (Golden Pear), a national leader in litigation finance for both pre-settlement and medical receivables, announced the extension and upsize of their investment-grade corporate notes to $78.7 million. Since its founding in 2008, Golden Pear has funded over $1.1 billion to more than 87,000 clients. Proceeds from the transaction will be used for flexible working capital and growth initiatives.

“This capital infusion is instrumental in our growth as we continue to provide financing for the rapidly expanding litigation finance market,” said Gary Amos, Chief Executive Officer of Golden Pear.  “We are grateful to have the backing of both our long-standing investor partners and new institutional supporters who share our vision.” 

Daniel Amsellem, Chief Financial Officer of Golden Pear, added, “The timing of this transaction aligns perfectly with our capital allocation strategy. These funds will be utilized to optimize our cost structure, enhance operational efficiency, and pursue strategic initiatives."

Brean Capital, LLC served as the Company’s exclusive financial advisor and sole placement agent in connection with the transaction.

Founded in 2008, Golden Pear is one of the largest specialty finance companies in the United States funding legal matters and purchasing medical receivables from physicians and medical centers.